carbapenems has been researched along with captopril in 5 studies
Studies (carbapenems) | Trials (carbapenems) | Recent Studies (post-2010) (carbapenems) | Studies (captopril) | Trials (captopril) | Recent Studies (post-2010) (captopril) |
---|---|---|---|---|---|
7,355 | 147 | 5,277 | 10,320 | 1,514 | 890 |
Protein | Taxonomy | carbapenems (IC50) | captopril (IC50) |
---|---|---|---|
Leukotriene A-4 hydrolase | Homo sapiens (human) | 3.6 | |
Angiotensin-converting enzyme | Homo sapiens (human) | 0.084 | |
Angiotensin-converting enzyme | Oryctolagus cuniculus (rabbit) | 0.0173 | |
Succinyl-diaminopimelate desuccinylase | Haemophilus influenzae Rd KW20 | 3.3 | |
Angiotensin-converting enzyme | Rattus norvegicus (Norway rat) | 0.1004 | |
Beta-lactamase | Pseudomonas aeruginosa | 5 | |
Angiotensin-converting enzyme 2 | Homo sapiens (human) | 0.011 | |
Beta-lactamase class B VIM-2 | Pseudomonas aeruginosa | 3.5 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 4 (80.00) | 24.3611 |
2020's | 1 (20.00) | 2.80 |
Authors | Studies |
---|---|
Iguchi, M; Kato, K; Kikuchi, A; Kuraoka, E; Kurosawa, T; Shibasaki, S; Shirasaka, Y; Suzuki, H; Tamai, I | 1 |
Brem, J; Gileadi, O; Lee, SY; McDonough, MA; McHugh, PJ; Schofield, CJ; van Berkel, SS; Walsh, TR; Zollman, D | 1 |
Arakawa, Y; Jin, W; Kimura, K; Kurosaki, H; Mori, S; Wachino, J; Yamaguchi, Y | 1 |
Akhter, S; Bayer, A; Christopeit, T; Leiros, HS; Samuelsen, Ø; Skagseth, S | 1 |
Do, TG; Huynh, PNH; Nguyen, DN; Nguyen, TT; Thai, KM; Tran, VH; Tran, VT; Vo, TP | 1 |
5 other study(ies) available for carbapenems and captopril
Article | Year |
---|---|
Intestinal absorption mechanism of tebipenem pivoxil, a novel oral carbapenem: involvement of human OATP family in apical membrane transport.
Topics: Administration, Oral; Animals; Anti-Bacterial Agents; Biological Transport, Active; Caco-2 Cells; Captopril; Carbapenems; Female; Humans; Hydrogen-Ion Concentration; Intestinal Absorption; Kinetics; Male; Oocytes; Organic Anion Transporters; Peptide Transporter 1; Rats; Rats, Sprague-Dawley; Symporters; Xenopus | 2010 |
Structural Basis of Metallo-β-Lactamase Inhibition by Captopril Stereoisomers.
Topics: Angiotensin-Converting Enzyme Inhibitors; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamase Inhibitors; beta-Lactamases; Captopril; Carbapenems; Cloning, Molecular; Crystallography, X-Ray; Drug Repositioning; Enterobacteriaceae; Gene Expression; Hydrolysis; Kinetics; Microbial Sensitivity Tests; Models, Molecular; Recombinant Proteins; Stereoisomerism; Structure-Activity Relationship | 2016 |
Structural Insights into Recognition of Hydrolyzed Carbapenems and Inhibitors by Subclass B3 Metallo-β-Lactamase SMB-1.
Topics: Angiotensin-Converting Enzyme Inhibitors; Anti-Bacterial Agents; beta-Lactamases; Captopril; Carbapenems; Catalytic Domain; Crystallography, X-Ray; Doripenem; Imipenem; Meropenem; Mesna; Protein Structure, Secondary; Protein Structure, Tertiary; Serratia marcescens; Thienamycins | 2016 |
Structural Insights into TMB-1 and the Role of Residues 119 and 228 in Substrate and Inhibitor Binding.
Topics: Achromobacter denitrificans; Bacterial Proteins; beta-Lactamase Inhibitors; beta-Lactamases; Captopril; Carbapenems; Microbial Sensitivity Tests; Surface Plasmon Resonance | 2017 |
The Effects of One-Point Mutation on the New Delhi Metallo Beta-Lactamase-1 Resistance toward Carbapenem Antibiotics and β-Lactamase Inhibitors: An In Silico Systematic Approach.
Topics: Anti-Bacterial Agents; Bacteria; beta-Lactamase Inhibitors; beta-Lactamases; Captopril; Carbapenems; Microbial Sensitivity Tests; Point Mutation; Thiorphan | 2022 |